The U.S. Food and Drug Administration (FDA) this week approved the first generic versions of the antidepressant duloxetine, commonly marketed as cymbalta side effects
The drug is just a delayed-release medication used to deal with depression and various other specific conditions.
The brand new generic versions of Cymbalta will function just like the branded version of the drug, and at the same strength. And also this means, however, that the generic version carries exactly the same side effects of Cymbalta, including nausea, dry mouth, drowsiness, fatigue, decreased appetite, excessive sweating, and dizziness. The drugs also carry the increased risk of suicidal thinking in those younger than 24 years old ? a complication noticed in many different antidepressant drugs.
The approval of the generic version of Cymbalta brings the drug to market in the U.S. at a much lower price, allowing the drug to be employed by a broader segment of Americans who may not have the ability to afford manufacturer drugs.
The FDA emphasized that generic versions of drugs are only as potent as their branded counterparts. The generics feel the same approval procedures as branded drugs and generic drug manufacturers and packagers must meet the same standards as those that manufacture and pack brand names. The generics must come with medication guides.
?Medical care professionals and consumers can rest assured these FDA-approved generic drugs have met our rigorous standards,? said Dr. Kathleen Uhl, acting director of the Office of Generic Drugs at the FDA. ?Generic drugs offer greater access to medical care for most people.?